Furthermore, cancer progression phase-dependent regulation of CTGF is crucial to the malignancy of latent competent cancer stem cells through the non-canonical Wnt activation, even though the growth of ribosome-insulted cancer cells is decreased. The gene discussed is CCN2; the disease is cancer.